BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9343590)

  • 1. Autoradiographic evidence that QNB displays in vivo selectivity for the m2 subtype.
    McRee RC; Boulay SF; Sood VK; Cohen EI; Cohen VI; Gitler MS; Zeeberg BR; Gibson RE; Reba RC
    Neuroimage; 1995 Mar; 2(1):55-62. PubMed ID: 9343590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic evidence that 3-quinuclidinyl-4-fluorobenzilate (FQNB) displays in vivo selectivity for the m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Cohen VI; Zeeberg BR; Reba RC
    Neuroimage; 1996 Feb; 3(1):35-9. PubMed ID: 9345473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiographic evidence that quinuclidinyl 4-(bromophenyl)-2-thienylglycolate (QBPTG) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; McRee RC; Cohen EI; Cohen VI; Zeeberg BR; Reba RC
    Neuroimage; 1995 Sep; 2(3):209-13. PubMed ID: 9343604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo autoradiographic competition studies of isomers of [125I]IQNP against QNB demonstrating in vivo m2 muscarinic subtype selectivity for QNB.
    Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Knapp FF
    Recept Signal Transduct; 1997; 7(1):45-54. PubMed ID: 9285530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vivo rat brain regional pharmacokinetics of [3H]QNB, (R,S)-[125I]-4IQNB, and (R,R)-[125I]-4IQNB binding to the muscarinic acetylcholine receptor in relationship to the regional subtype composition.
    Boulay SF; Gitler MS; Sood VK; Cohen VI; Zeeberg BR; Reba RC
    Receptor; 1995; 5(4):207-18. PubMed ID: 8840399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoradiographic evidence that (R)-3-quinuclidinyl (S)-4-fluoromethylbenzilate ((R,S)-FMeQNB) displays in vivo selectivity for the muscarinic m2 subtype.
    Boulay SF; Sood VK; Rayeq MR; Zeeberg BR; Eckelman WC
    Nucl Med Biol; 1996 Oct; 23(7):889-96. PubMed ID: 8971856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]QNB displays in vivo selectivity for the m2 subtype.
    Gitler MS; De la Cruz R; Zeeberg BR; Reba RC
    Life Sci; 1994; 55(19):1493-508. PubMed ID: 7968217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo m2 muscarinic subtype selectivity of some dibenzodiazepinones and pyridobenzodiazepinones.
    Cohen VI; Jin B; McRee RC; Boulay SF; Cohen EI; Sood VK; Zeeberg BR; Reba RC
    Brain Res; 2000 Apr; 861(2):305-15. PubMed ID: 10760492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo competition studies of Z-(-,-)-[125I]IQNP against 3-quinuclidinyl 2-(5-bromothienyl)-2-thienylglycolate (BrQNT) demonstrating in vivo m2 muscarinic subtype selectivity for BrQNT.
    Cohen VI; Zeeberg BR; Boulay SF; Sood VK; Rayeq MR; Danesh RA; McPherson DW; Reba RC
    J Mol Neurosci; 1998 Aug; 11(1):1-9. PubMed ID: 9826782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel muscarinic receptor ligand which penetrates the blood brain barrier and displays in vivo selectivity for the m2 subtype.
    Gitler MS; Cohen VI; De la Cruz R; Boulay SF; Jin B; Zeeberg BR; Reba RC
    Life Sci; 1993; 53(23):1743-51. PubMed ID: 8246670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo autoradiographic and dissection evaluation of isomers of 125I-labeled 1-azabicyclo[2.2.2] oct-3-yl-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate (IQNP).
    Rayeq MR; Boulay SF; Sood VK; McPherson DW; Knapp FF; Zeeberg BR
    Recept Signal Transduct; 1996; 6(1):13-34. PubMed ID: 8933619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic innervation and topographical organization of muscarinic binding sites in rat brain: a comparative autoradiographic study.
    Tonnaer JA; Ernste BH; Wester J; Kelder K
    J Chem Neuroanat; 1988; 1(2):95-110. PubMed ID: 3267343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
    Piggott MA; Owens J; O'Brien J; Colloby S; Fenwick J; Wyper D; Jaros E; Johnson M; Perry RH; Perry EK
    J Chem Neuroanat; 2003 Mar; 25(3):161-73. PubMed ID: 12706204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain.
    Lee J; Paik CH; Kiesewetter DO; Park SG; Eckelman WC
    Nucl Med Biol; 1995 Aug; 22(6):773-81. PubMed ID: 8535338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding kinetics of quinuclidinyl benzilate and methyl-quinuclidinyl benzilate enantiomers at neuronal (M1), cardiac (M2), and pancreatic (M3) muscarinic receptors.
    Waelbroeck M; Tastenoy M; Camus J; Christophe J
    Mol Pharmacol; 1991 Sep; 40(3):413-20. PubMed ID: 1896027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective, unilateral cortical infarction increases striatal muscarinic receptor binding: potential evidence for cortical modulation of intrastriatal cholinergic transmission.
    Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK
    J Chem Neuroanat; 1990; 3(2):125-32. PubMed ID: 2340116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of 3-quinuclidinyl 4-[125I]iodobenzilate transport and specific binding to muscarinic acetylcholine receptor in rat brain in vivo: implications for human studies.
    Sawada Y; Hiraga S; Francis B; Patlak C; Pettigrew K; Ito K; Owens E; Gibson R; Reba R; Eckelman W
    J Cereb Blood Flow Metab; 1990 Nov; 10(6):781-807. PubMed ID: 2134838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of in vivo brain muscarinic acetylcholine receptor subtype selectivity by competition studies against (R,S)-[125I]IQNB.
    Gitler MS; Boulay SF; Sood VK; McPherson DW; Knap FF; Zeeberg BR; Reba RC
    Brain Res; 1995 Jul; 687(1-2):71-8. PubMed ID: 7583315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic simulations of SPECT quantitation of the M2 muscarinic neuroreceptor subtype in disease states using radioiodinated (R,R)-4IQNB.
    Zeeberg BR; Kim HJ; Reba RC
    Life Sci; 1992; 51(9):661-70. PubMed ID: 1501511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional distribution of [3H]quinuclidinyl benzilate binding to muscarinic cholinergic receptors in the developing human brainstem.
    Kinney HC; Panigrahy A; Rava LA; White WF
    J Comp Neurol; 1995 Nov; 362(3):350-67. PubMed ID: 8576444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.